# Amrutanjan Health Care (NSE: AMRUTANJAN) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/AMRUTANJAN · Pivot · prices to 21 Oct 2026

Amrutanjan Health Care (NSE: AMRUTANJAN) closed at ₹500.65 on 21 Oct 2026. With a market capitalisation of ₹1,448 Cr, it ranks 1297th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 25× trailing earnings, against a return on equity of 16.8% in FY17. Over the past year the share price has fallen 28.8%. Its 52-week range is ₹476.50 (16 Sep 2026) to ₹760.15 (29 Oct 2025); the last close is 34.1% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹150 Cr (+10.6% year on year) and net profit ₹16 Cr (+6.7%), on a standalone basis. Promoters held 46.52% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹500.65 |
| Market cap | ₹1,448 Cr |
| P/E (trailing) | 25 |
| ROE | 16.8% (FY17) |
| ROCE | 23.9% (FY17) |
| Debt to equity | 0.02 |
| 52-week high | ₹760.15 (29 Oct 2025) |
| 52-week low | ₹476.50 (16 Sep 2026) |
| 1-year return | −28.8% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹150 Cr | +10.6% | ₹16 Cr | +6.7% | ₹5.60 |
| Q3 FY26 | ₹141 Cr | +14.9% | ₹19 Cr | +1.0% | ₹6.73 |
| Q2 FY26 | ₹118 Cr | +7.1% | ₹14 Cr | +18.3% | ₹4.83 |
| Q1 FY26 | ₹94 Cr | +12.3% | ₹8 Cr | +79.9% | ₹2.87 |
| Q4 FY25 | ₹135 Cr | +6.6% | ₹15 Cr | +11.1% | ₹5.25 |
| Q3 FY25 | ₹123 Cr | +4.9% | ₹19 Cr | +10.3% | ₹6.66 |
| Q2 FY25 | ₹110 Cr | +10.7% | ₹12 Cr | +72.3% | ₹4.08 |
| Q1 FY25 | ₹84 Cr | +7.6% | ₹5 Cr | −34.1% | ₹1.60 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY17 | ₹224 Cr | ₹21 Cr |
| FY16 | ₹187 Cr | ₹21 Cr |
| FY15 | ₹167 Cr | ₹15 Cr |
| FY14 | ₹142 Cr | ₹12 Cr |
| FY13 | ₹138 Cr | ₹10 Cr |
| FY12 | ₹143 Cr | ₹10 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 46.52%
- Foreign institutions: 2.44%
- Domestic institutions: 12.28%
- Non-institutions: 38.72%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Astec LifeSciences](https://app.pivotnow.in/stock/ASTEC) | ₹693.00 | ₹1,544 Cr | — | — |
| [Gujarat Kidney And Super Speciality](https://app.pivotnow.in/stock/GKSL) | ₹188.00 | ₹1,482 Cr | 75.5 | — |
| [Jagsonpal Ser](https://app.pivotnow.in/stock/JAGSNPHARM) | ₹217.95 | ₹1,435 Cr | 34.5 | — |
| [Anlon Healthcare](https://app.pivotnow.in/stock/AHCL) | ₹26.92 | ₹1,431 Cr | 44.1 | — |
| [TTK Healthcare](https://app.pivotnow.in/stock/TTKHLTCARE) | ₹1,007.60 | ₹1,424 Cr | 21.7 | — |
| [Shalby](https://app.pivotnow.in/stock/SHALBY) | ₹126.00 | ₹1,361 Cr | 38.9 | — |

## Questions and answers

### What is the share price of Amrutanjan Health Care today?

Amrutanjan Health Care (NSE: AMRUTANJAN) last closed at ₹500.65 on 21 Oct 2026. Its 52-week high is ₹760.15 and its 52-week low is ₹476.50.

### What is the market cap of Amrutanjan Health Care?

Amrutanjan Health Care's market capitalisation is ₹1,448 Cr (₹1,448 Cr) at the 19 Oct 2026 close, ranking 1297th among the NSE companies Pivot tracks.

### What is the P/E ratio of Amrutanjan Health Care?

Amrutanjan Health Care trades at a trailing P/E of 25. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 38.9.

### What is the ROE and ROCE of Amrutanjan Health Care?

Return on equity was 16.8% in FY17 and return on capital employed was 23.9% in FY17 (consolidated figures).

### Is Amrutanjan Health Care a debt-free company?

Amrutanjan Health Care is close to debt-free: its debt-to-equity ratio was 0.02 in FY17.

### What were Amrutanjan Health Care's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Amrutanjan Health Care reported revenue of ₹150 Cr, +10.6% year on year, and net profit of ₹16 Cr, +6.7% year on year.

### How has Amrutanjan Health Care stock performed over the last year?

Amrutanjan Health Care's share price has fallen 28.8% over the past year, −8.7% over three months and +2.1% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Amrutanjan Health Care?

As of 30 Jun 2026: promoters 46.52%, foreign institutions 2.44%, domestic institutions 12.28%, non-institutions 38.72%.

### Who are Amrutanjan Health Care's competitors?

The listed Pharma & Healthcare companies closest to Amrutanjan Health Care by market cap are Astec LifeSciences, Gujarat Kidney And Super Speciality, Jagsonpal Ser, Anlon Healthcare, TTK Healthcare and Shalby.

### Is Amrutanjan Health Care a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Amrutanjan Health Care's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on AMRUTANJAN against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.